Professor Sir Mark Caulfield, President of the BPS 2024-2026
2024 was the first year of my Presidency at the BPS, and the external turbulence caused by global political and social events showed no signs of abating. I’ve been privileged to witness the strength of our community throughout this, and the vital role pharmacology continues to play in addressing the health challenges of our time.
From accelerating innovation in research to strengthening education, our members have made remarkable contributions across the field. Nowhere was this more evident than at Pharmacology 2024, where we came together to share knowledge, spark ideas, and reaffirm our shared commitment to science that improves lives.
Looking to the future, I believe passionately that our greatest responsibility — and our greatest opportunity — lies in supporting the next generation. The future of our discipline, and of the Society itself, does not lie with people who look like me. It lies with a new wave of pharmacologists — more diverse in background, experience, and perspective — who will take our science to places we haven’t yet imagined. Our role is to create the conditions for them to thrive. We must ensure that we are a welcoming place for younger members, and broaden our church, be open to adapting to our members needs. This is how we will remain strong, stable, and member-focused so that no matter the turmoil outside, we can keep delivering the scientific advancements that will make the world a better place.
That’s why I’m especially proud of the Society’s continued work to build a more inclusive and supportive environment for early career scientists, to widen participation, and to ensure that excellence in pharmacology is truly accessible to all.
We are in a period of rapid change — in science, in society, and in the world around us. But with change comes opportunity. I have every confidence that the British Pharmacological Society is ready to meet this moment and to lead with purpose, humility, and hope.
Thank you to everyone who has contributed to another outstanding year.
---
Next:
Strengthening the foundation of clinical pharmacology
Previous:
Message from the CEO
Go back to
Annual Review 2024